Predictmedix AI Executives Departing This Weekend for Strategic Collaborations in India
- None.
- None.
TORONTO, ON / ACCESSWIRE / September 20, 2023 / Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) (the "Company" or "Predictmedix") today announced that visas have been granted for a strategic visit to India. The primary purpose of the company's executives' visit is to engage with institutional partners and government officials in India, with a keen focus on ensuring seamless integration and scalable deployment of Predictmedix's cutting-edge contactless AI solutions. This strategic move underscores the company's commitment to revolutionizing healthcare and enhancing various industry sectors through the power of AI.
India, with its dynamic and rapidly evolving market, offers a unique opportunity for Predictmedix AI to make a significant impact. By collaborating with local partners and government authorities, we aim to usher in a future where AI-driven technologies enhance efficiency, safety, and the overall well-being of the nation.
"Our visit to India holds immense importance for us, as we look forward to collaborating with institutional partners and government officials to bring our transformative AI solutions to a wider audience. By ensuring seamless integration and scalable deployment, we aim to make a significant positive impact on healthcare and various other sectors in India. We believe that this collaboration will pave the way for a future where AI-driven technologies enhance efficiency, safety, and the overall well-being of the nation," commented Dr. Rahul Kushwah, COO of Predictmedix AI.
About Predictmedix AI Inc.
Predictmedix AI Inc. (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) is an emerging provider of rapid health screening and remote patient care solutions globally. The Company's Safe Entry Stations - powered by a proprietary artificial intelligence (AI) - use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including infectious diseases such as COVID-19, impairment by drugs or alcohol, fatigue, or various mental illnesses. Predictmedix AI's proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. To learn more, please visit our website at www.Predictmedix.com or follow us on Twitter, Instagram or LinkedIn.
Public Relations Contact
For further media information or to set up an interview, please contact:
Nelson Hudes
Communications International (905) 660 9155
Nelson@hudescommunications.com
Dr. Rahul Kushwah (647) 889 6916
Caution Regarding Forward-Looking Information:
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results of the Company. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances. The Company's securities have not been registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or "U.S. Persons", as such term is defined in Regulations under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful. Additionally, there are known and unknown risk factors which could cause the Company's actual results, performance or achievements to be materially different from any Page 4 of 4 future results, performance or achievements expressed or implied by the forward-looking information contained herein, such as, but not limited to dependence on obtaining regulatory approvals; the ability to obtain intellectual property rights related to its technology; limited operating history; general business, economic, competitive, political, regulatory and social uncertainties, and in particular, uncertainties related to COVID-19; risks related to factors beyond the control of the Company, including risks related to COVID-19; risks related to the Company's shares, including price volatility due to events that may or may not be within such party's control; reliance on management; and the emergency of additional competitors in the industry.
All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except required by law.
Disclaimer: "The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED NOR DOES IT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
SOURCE: Predictmedix AI Inc.
View source version on accesswire.com:
https://www.accesswire.com/785774/predictmedix-ai-executives-departing-this-weekend-for-strategic-collaborations-in-india
